Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07453082 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Prospective Study to Evaluate miRNA371 and Outcomes in Patients With Newly Diagnosed Germ Cell Tumors

Study acronym: BRIDGE
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 5, 2026 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This is a observational study aimed at evaluating miRNA 371a-3p (miRNA 371) as a specific marker for presence or absence of clinically detectable viable germ cell malignancy.
Trial Details
NCT Number NCT07453082
Lead Sponsor Fondazione del Piemonte per l'Oncologia
Conditions
(from sponsor)		 Testicular Germ Cell Tumor
Related terms Testicular Germ Cell Tumor
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov